S
Sonoma Biotherapeutics
1 follower
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approac... Read more
Org chart
Jeff Bluestone
CEO & President
Jeff Bluestone
Collapse
Fred Ramsdell
Chief Scientific Officer
Peter Dilaura
Chief Business & Strategy Officer
Doug Sheehy
Chief Legal Officer & Secretary
Jimmy Chung
Director, Information Technology
Melisa S. Medrano
Director Of Talent
Teams
Offices
Similar companies
- Something went wrong loading the org chart, please refresh the page.